{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for l root_codes_comments in Code Comments (approximate match)
Status:
US Previously Marketed
Source:
21 CFR 310.527(a) hair loss prevention polysorbate 20
Source URL:
First approved in 1978
Source:
60-Second Fluoride Pina Colada by Patterson Dental Supply Inc
Source URL:
Class:
POLYMER
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(20) weight control alginic acid
Source URL:
First approved in 1959
Source:
ANDA205126
Source URL:
Class:
POLYMER
Status:
US Previously Marketed
Source:
TODAY by MAYER LABS INC
(1983)
Source URL:
First approved in 1959
Class:
POLYMER
Conditions:
Nonoxynol-9, is an organic compound that is used as a surfactant and vaginal spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms. Nonoxynol-9 interacts with the lipids in the membranes of the acrosome and the midpiece of the sperm. The sperm membranes are lysed; the acrosome, neck and midpiece of the spermatozoa are loosened and then detached which results in their immobilization and death. Nonoxynol-9 offers no protection against sexually transmitted infections such as gonorrhoea, chlamydia and does not prevent HIV infection and may even favour infection if used frequently. A possible reason, is that nonoxynol-9 can disrupt the epithelium, or wall, of the vagina, thereby potentially facilitating invasion by an infective organism and virus. Nonoxynol-9 and related compounds are ingredients in various cleaning and cosmetic products.
Status:
Possibly Marketed Outside US
Source:
FLUIDBASE AHA 10 by LABORATORIO GENOVE S.A.
(2016)
Source URL:
First approved in 1983
Source:
NDA018861
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1950
Source:
NDA007073
Source URL:
Class:
POLYMER
Cellacefate is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations. Cellacefate's use in enteric coatings allows tablets to remain intact in the unfavorable gastric acid secretion of the stomach, but dissolve in the more basic areas of the duodenum, thus protecting the stomach from ulceration or allowing greater absorption form the duodenum. Cellacefate is a reaction product of phthalic anhydride and a partial acetate ester of cellulose.
Status:
US Approved Rx
(2013)
First approved in 1942
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 349.14(b)(4) ophthalmic:emollient petrolatum
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 358.710(c)(1) dandruff:psoriasis coal tar
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 349.14(b)(3) ophthalmic:emollient paraffin
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 349.14(a)(2) ophthalmic:emollient lanolin (in combination)
Source URL:
First marketed in 1921
Source:
Hydrous Wool Fat U.S.P.
Source URL:
Class:
STRUCTURALLY DIVERSE